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Figure SI-1: Dimensions of the separation channel. 
The channel dimensions are shown in top-view. The nominal thickness of the channel was 
350 µm. 
 
 
Figure SI-2: Size determinations by AF4/MALLS and comparison of the different ways for 
calculation of the size distributions. 
Elution profile of drug-free liposomes (batch 1) together with the diameters determined over 
elution (A) and size distributions (B) calculated by the binning method (blue dots) and by 
fitting the size curve in A (red curve in B, polynominal fit 3rd order). 
Although both approaches results in some differences particularly at the lower end of the size 
distribution (B), there was overall a good agreement and the characteristic diameters (D10, 
D50 and D90) were very similar for the binning and fit method: 60.1 vs. 59.8 nm (D10), 86.6 
vs. 87.2 nm (D50) and 107.4 vs. 107.7 nm (D90). As the small shoulder at the lower end of 
the size distribution obtained by the binning method was observed in all liposome suspensions 
and a fit cannot be applied on the slice data of multimodal samples (i.e. mixture of the 
standard polystyrene nanoparticles) due to steps in the size versus time curve, the binning 
method was applied throughout this study.  
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Figure SI-3: Size results in dependence on the applied focus conditions. 
Characteristic diameters determined from the cumulative mass distributions (n = 3) of drug-
free liposomes measured with different focus conditions. Results of measurements of drug-
free liposomes prepared in 5% glucose solution (batch 2) and measured in water are shown. 
 
Figure SI-4: Elution profiles and size results in dependence on the applied cross flow 
gradient. 
Representative elution profiles (A) and size results (B, characteristic diameters determined 
from the cumulative mass distribution, n = 3) at different cross flow gradients. Results of 
measurements of drug-free liposomes prepared in 5% glucose solution (batch 1) and measured 
in water are shown.  
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Figure SI-5: Influence of injected sample mass on size results and RI-detector signals. 
Dependence of the size results (A, characteristic diameters calculated from the cumulative 
mass distribution) and the peak area of the RI-detector signals (B) on the injected sample 
mass. Drug-free liposomes prepared in 5% glucose solution (batch 1) were evaluated in a 
range of injected liposome mass from 5 to 200 µg (n = 3).  
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Figure SI-6: Elution profile and size distribution of liposomes prepared in 5% glucose 
solution and measured in different carrier liquids. Z-average values of the liposomes in the 
various liquids over 14 days.  
Representative AF4 elution profiles (A, B), cumulative mass-weighted size distributions (C, 
D) and PCS z-average diameters over 14 days (E, F) of drug-free (A, C, E, batch 1) and 
mTHPC-loaded (B, D, F) liposomes prepared in 5% glucose solution are shown. Liposomes 
were diluted and measured in water and sodium chloride solutions (25, 50 and 100 mM). The 
polydispersity indices were ≤ 0.1 in all PCS measurements. 
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Figure SI-7: Elution profile and size distribution of liposomes prepared in water and 
measured in different carrier liquids. 
Representative AF4 elution profiles (A) and cumulative mass-weighted size distributions (B) 
of drug-free liposomes prepared in water and diluted and measured in pure water and sodium 
chloride solutions (25, 50 and 100 mM).  
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Figure SI-8: Size distributions of drug-loaded liposomes. 
Representative size distributions of the drug-loaded liposomes measured in water: (A) 
mTHPC, (B) testosterone and (C) corticosterone. 
